|Articles|June 1, 2004

Ruboxistaurin slows central DME, does not halt progression

Inhibition of PKC shown to affect changes in retinal blood flow as well as leukocyte adhesion

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME